Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q3 2026 56/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Portfolio timeline

Baker Bros. Advisors — Portfolio History

Every 13F quarter on record, newest first. Each row lists the quarter's top positions; open any quarter for the full portfolio, buys, adds, trims and exits.

Quarters
4
Avg positions
83.5
Latest top 5 weight
58.5%
Avg top 5 weight
53.8%
Avg changed names
37.7
Held in ≥75% of stored quarters
75

Quarter Activity

Reported increases, decreases, exits, and new positions vs. the prior filing.

Quarter New Adds Trims Exits Top 5
Q3 2026 5 9 11 9 58.5%
Q2 2026 8 16 7 8 52%
Q1 2026 7 18 6 9 50.5%
Q4 2025 No prior baseline 54.2%

Most Frequently Reported Positions

Positions appearing across the most stored reporting quarters.

Position Quarters Latest weight Latest value
INCY Incyte Corp. 4 17.7% $3.7B
ONC Beigene Ltd-Adr 4 15.4% $3.2B
RVMD Revolution Medicines 4 10.4% $2.2B
KOD Kodiak Sciences Inc. 4 9.9% $2.1B
MDGL Madrigal Pharmaceuticals Inc. 4 5.1% $1.1B
INSM Insmed Inc. 4 4.8% $1.0B

Tip: hover any ticker below to see its weight in that quarter's portfolio.

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.